A Two-Compartment Population Pharmacokinetic–Pharmacodynamic Model of Digoxin in Adults, With Implications for Dosage

Therapeutic Drug Monitoring - United States
doi 10.1097/ftd.0000000000000023
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

AAPS Journal
Pharmaceutical Science
2018English

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design

PLoS ONE
Multidisciplinary
2015English

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Population Pharmacokinetic Analysis of Digoxin in Chinese Neonates and Infants

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

Pharmacokinetic Considerations for Digoxin in Older People

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2011English

Bridging Adults and Paediatrics With Secondary Hyperparathyroidism Receiving Haemodialysis: A Pharmacokinetic-Pharmacodynamic Analysis of Cinacalcet

British Journal of Clinical Pharmacology
Pharmacology
2019English

Clinical Evaluation of Population Pharmacokinetic Parameters in Phenytoin Dosage Adjustment.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1989English

Amphotericin B Deoxycholate in Adults With Cryptococcal Meningitis; A Population Pharmacokinetic Model and Meta-Analysis of Outcomes

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy